Detalhe da pesquisa
1.
Immunotherapy Combining Mimotopes Selected by Phage Display Plus Amphotericin B Is Effective for Treatment Against Visceral Leishmaniasis.
Parasite Immunol
; 46(5): e13037, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720446
2.
Development of an immunogen containing CD4+/CD8+ T-cell epitopes for the prophylaxis of tegumentary leishmaniasis.
Appl Microbiol Biotechnol
; 106(12): 4627-4641, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759035
3.
Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection.
Parasitology
; 142(10): 1335-47, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26099574
4.
Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis.
Exp Parasitol
; 153: 180-90, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25845753
5.
In Silico Design of Recombinant Chimera T Cell Peptide Epitope Vaccines for Visceral Leishmaniasis.
Methods Mol Biol
; 2410: 463-480, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914063
6.
Preclinical Assessment of the Immunogenicity of Experimental Leishmania Vaccines.
Methods Mol Biol
; 2410: 481-502, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914064
7.
A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
Immunobiology
; 222(2): 251-260, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27693018
8.
Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection.
Parasit Vectors
; 10(1): 617, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29268793
9.
Performance of Leishmania braziliensis enolase protein for the serodiagnosis of canine and human visceral leishmaniosis.
Vet Parasitol
; 238: 77-81, 2017 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28385540
10.
Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis.
Rev Soc Bras Med Trop
; 49(4): 398-407, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27598624
11.
A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis.
Acta Trop
; 154: 73-81, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26593442
12.
Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system.
Parasitol Int
; 65(6 Pt A): 728-736, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27425599
13.
Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species.
Acta Trop
; 158: 220-230, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976272
14.
Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
Vet Parasitol
; 215: 63-71, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26790739
15.
Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis.
PLoS One
; 10(9): e0137683, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26367128
16.
Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.
PLoS One
; 9(10): e110014, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25333662
17.
Strychnos pseudoquina and Its Purified Compounds Present an Effective In Vitro Antileishmanial Activity.
Evid Based Complement Alternat Med
; 2013: 304354, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24194781
18.
Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis
Rev. Soc. Bras. Med. Trop
; 49(4): 398-407, July-Aug. 2016. tab, graf
Artigo
em Inglês
| LILACS | ID: lil-792794
19.
Correction: Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis.
PLoS One
; 10(10): e0141496, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26485004